The therapeutic potential of modulating GITR-GITRL interactions is explored through agonistic approaches that enhance tumor immune responses and strategies to dampen excessive immune reactions in autoimmune and inflammatory diseases (33). This evidence concerns the gene TNFRSF18 and neoplasm.